Markus Raderer undertook his early medical studies at the Medical University of Vienna, completing his residency in internal medicine between 1993 and 1999, specialising in haematology and oncology in 2001. He received the venia docendi for ‘Applied and Experimental Oncology’ and ‘Internal Medicine’ in 1999 and 2002, respectively. Professor Raderer is currently Deputy Head of the Department of Oncology, Medical University Vienna, he is heading the Clinical Research Unit and is Programme Director for Extranodal Lymphomas. He has been responsible for the management and conduct of phase II and III clinical trials at his institution since 1992.
Professor Raderer is on the Editorial Board of a number of journals including a 6 year term on the Journal of Clinical Oncology, World Journal of Gastroenterology, and Middle European Journal of Medical Oncology. He has participated on consensus panels for the European Gastrointestinal Lymphoma Study Group (EGILS) on the topic of B-cell lymphoma of mucosa-associated lymphoid tissue, and the European Society for Medical Oncology (ESMO) on the subject of the management of lymphoid malignancies and is first author of the “Onkopedia” therapeutic guidelines for extranodal marginal zone lymphomas of the German Society of Hematology and Oncology (DGHO).